Intel rises 2% on report of $8 billion Chips Act grant
Investing.com -- Intel Corporation (NASDAQ:INTC) shares rose 2% in premarket trading Monday following a CNBC report that the chipmaker was nearing a deal with the U.S. Commerce Department for a nearly $8 billion grant under the Chips Act, according to sources familiar with the matter.
The report further added that the Commerce Department was expected to finalize the awards in the coming weeks, with Intel’s grant earmarked for its factory-building initiatives.
The $52.7 billion Chips and Science Act, aimed to bolster domestic semiconductor production, includes $39 billion in subsidies for manufacturing and $11 billion for research and development.
Intel and the Commerce Department did not immediately respond to Investing.com’s request for comment.
The chipmaker’s stock has struggled this year as slowing demand in the PC market has weighed on its performance. In response, Intel has cut thousands of jobs, suspended its dividend, and sought government grants and contracts to support its manufacturing business, which has been losing money.
Related Articles
Oklo Stock Price Drops 24% After Oklo Earnings Released: What's Oklo Stock Price Target? Is Oklo Stock a Buy Now?
TradingKey - Oklo, a California-based advanced nuclear technology company backed by OpenAI CEO Sam Altman, currently remains unprofitable. Founded in 2013, the firm specializes in designing and building small modular reactors (SMRs), aiming to provide clean, reliable energy solutions. Furthermore, A
The Jobs Puzzle During the Shutdown: From Weak ADP to a Rebounding September NFP and an October Surprise Dip
TradingKey - The longest US government shutdown on record is nearing its end, potentially providing the data-deprived Federal Reserve with the September nonfarm payrolls report as early as this week once federal operations resume. However, the October nonfarm data may be permanently lost. During the
CoreWeave Q3 2025 Earnings Analysis: Short-Term Hypergrowth vs. Long-Term Leverage Risks—Trading Opportunity or Trap?
CoreWeave Q3 2025: Revenue +134% to $1.36B, loss narrows to $110M, but guidance cut, op margin 4%, $14B debt. AI infra boom via NVIDIA/OpenAI deals, 50%+ GPU util, $55.6B backlog. Short-term trade, long-term leverage trap.
Strategy (MSTR): Why This Bitcoin Proxy Is Decoupling From BTC — And Is It Still a Buy?
TradingKey - Strategy stock is in a sustained decline and remains entrenched in a downward channel, as Bitcoin continues to fall and briefly dipped below $100,000 on November 4, leading to a sharp decline in Bitcoin-related stocks. We believe Strategy’s slump has not yet abated.
